Steven Cohen's SNY Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 331,765 shares of Sanofi (SNY) worth $16.08 M, representing 0.02% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in SNY, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2022, adding 1.41 M shares. Largest reduction occurred in Q4 2022, reducing 1.23 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Sanofi (SNY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sanofi (SNY) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -37,569 | Reduce 10.17% | 331,765 | $48.46 |
| Q3 2025 | +369,334 | New Buy | 369,334 | $47.20 |
| Q1 2025 | -950,649 | Sold Out | 0 | $0.00 |
| Q4 2024 | +861,770 | Add 969.60% | 950,649 | $48.23 |
| Q3 2024 | -122,609 | Reduce 57.97% | 88,879 | $57.63 |
| Q2 2024 | +211,488 | New Buy | 211,488 | $48.52 |
| Q1 2024 | -766,300 | Sold Out | 0 | $0.00 |
| Q4 2023 | +766,300 | New Buy | 766,300 | $49.73 |
| Q1 2023 | -500,000 | Sold Out | 0 | $0.00 |
| Q4 2022 | -1.23 M | Reduce 71.06% | 500,000 | $48.43 |
| Q3 2022 | +1.41 M | Add 446.79% | 1.73 M | $38.02 |
| Q2 2022 | -1.01 M | Reduce 76.16% | 315,984 | $50.03 |
| Q1 2022 | -488,869 | Reduce 26.94% | 1.33 M | $51.34 |
| Q4 2021 | -693,805 | Reduce 27.66% | 1.81 M | $50.10 |
| Q3 2021 | +1.1 M | Add 77.94% | 2.51 M | $48.21 |
| Q2 2021 | +352,229 | Add 33.31% | 1.41 M | $52.66 |
| Q1 2021 | +42,400 | Add 4.18% | 1.06 M | $49.46 |
| Q4 2020 | +286,176 | Add 39.27% | 1.02 M | $48.59 |
| Q3 2020 | -113,936 | Reduce 13.52% | 728,824 | $50.17 |
| Q2 2020 | +287,760 | Add 51.85% | 842,760 | $51.05 |
| Q1 2020 | +276,100 | Add 99.00% | 555,000 | $43.72 |
| Q4 2019 | -721,100 | Reduce 72.11% | 278,900 | $50.20 |
| Q3 2019 | -285,000 | Reduce 22.18% | 1 M | $46.33 |
| Q2 2019 | +885,000 | Add 221.25% | 1.28 M | $43.27 |
| Q1 2019 | -50,000 | Reduce 11.11% | 400,000 | $44.28 |
| Q4 2018 | +250,000 | Add 125.00% | 450,000 | $43.41 |
| Q3 2018 | +87,500 | Add 77.78% | 200,000 | $44.67 |
| Q2 2018 | -37,500 | Reduce 25.00% | 112,500 | $40.01 |
| Q1 2018 | +150,000 | New Buy | 150,000 | $40.08 |
| Q1 2015 | -1.05 M | Sold Out | 0 | $0.00 |
| Q4 2014 | +1.05 M | New Buy | 1.05 M | $45.61 |
Steven Cohen's Sanofi Investment FAQs
Steven Cohen first purchased Sanofi (SNY) in Q4 2014, acquiring 1,050,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Sanofi (SNY) for 31 quarters since Q4 2014.
Steven Cohen's largest addition to Sanofi (SNY) was in Q3 2022, adding 1,727,777 shares worth $65.69 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 331,765 shares of Sanofi (SNY), valued at approximately $16.08 M.
As of the Q4 2025 filing, Sanofi (SNY) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Sanofi (SNY) was 2,508,305 shares, as reported at the end of Q3 2021.